GI
BNGO icon

Gradient Investments’s Bionano Genomics BNGO Stock Holding History

Gradient Investments’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5
Closed -$203 – 417
2024
Q2 		$203 Buy
+5
New +$275 ﹤0.01% 1266
2023
Q3 		– Hold
0
– -$3 – 1817
2023
Q2 		– Hold
0
– – – 1764
2023
Q1 		– Hold
0
– – – 1493
2022
Q4 		– Hold
0
– – – 1484
2022
Q3 		– Hold
0
– – – 1354
2022
Q2 		– Hold
0
– – – 1229
2022
Q1 		– Hold
0
– – – 1189
2021
Q4 		– Hold
0
– – – 1231
2021
Q3 		– Hold
0
– – – 1147
2021
Q2 		– Hold
0
– – – 1152
2021
Q1 		– Hold
0
– – – 1155

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

Gradient Investments's BNGO Position: Q3 2024 in Review

Gradient Investments sold out of Bionano Genomics (BNGO) in Q3 2024, closing a stake of 5 shares — an estimated $203 sold.

Gradient Investments first reported a position in BNGO in Q2 2024 and held it in 1 quarter. The position peaked at $203 in Q2 2024. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • Gradient Investments reported no remaining Bionano Genomics position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 5 Bionano Genomics shares in Q3 2024, an estimated $203.
  • Gradient Investments first reported a position in Bionano Genomics in Q2 2024 and held it in 1 quarter.
  • Gradient Investments's Bionano Genomics position peaked at $203 in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.